期刊文献+

糖化血红蛋白和内皮素变化与冠状动脉粥样硬化的关系 被引量:12

Correlation between coronary artery disease and levels of glycosylated hemoglobin and endothelin
下载PDF
导出
摘要 目的探讨糖化血红蛋白(HbA1c)和内皮素(ET)水平与冠状动脉粥样硬化之间的关系及其测定的临床意义。方法连续入选住院患者572例,根据血糖水平和冠状动脉造影结果将研究对象分为4组:阴性对照组40例、单纯糖尿病(DM)组50例、单纯冠心病(CHD)组262例、DM合并CHD组220例。比较4组之间HbA1c水平及ET水平的差异,并通过Logistic回归分析,探讨其与冠状动脉粥样硬化的关系。结果 HbA1c水平:对照组、单纯CHD组<单纯DM组<DM合并CHD组,对照组与单纯CHD组比较,差异无统计学意义(P>0.05);ET水平:对照组<单纯CHD组、单纯DM组<DM合并CHD组,单纯CHD与单纯DM组比较,差异无统计学意义(P>0.05)。ET为CHD发病独立危险因素,而HbA1c与CHD发病无明显相关。结论ET较HbA1c与CHD有更好的相关性,但DM患者会对结果判定造成偏倚,综合检测HbA1c与ET,有利于CHD合并DM更准确的诊断。 Objective To analysis the correlation between coronary atherosclerosis and levels of glycated hemoglobin (HbA1c) and endothelin(ET ) ,furthermore to explore the clinical significance of the two indexes in the department of cardiology .Methods 572 inpatients were divided into four groups according to the blood glucose level and coronary angiography results :negative control group with 40 patients ,simplex DM group with 50 patients ,simplex CHD group with 262 patients ,CHD+DM group with 220 pa-tients .The HbA1c and ET levels in the four groups were monitored ,and the correlations between the two indexes and coronary ath-erosclerosis were analysed by Logistic regression analyses .Results HbA1c level :control group and CHD group 〈 DM group〈CHD+DM group .No significant differences were observed between control group and CHD group (P〉 0 .05) .ET level :control group 〈 CHD group and DM group 〈 CHD+DM group .No significant differences were observed between CHD group and DM group(P〉0 .05) .After adjusted the potential risk factors such as age ,sex ,body mass index ,smoking ,the history of hypertension and blood glucose levels with binomial Logistic regression analysis the content of ET was relevant to the onset of CHD ,however HbA1c not .Conclusion ET has obviously correlation with coronary atherosclerosis ,however the simplex DM may cause false posi-tive interferences .Combined determination of HbA1c and ET is beneficial in the preliminary diagnosis of CHD and DM .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第24期3163-3164,3167,共3页 Chongqing medicine
关键词 冠心病 糖尿病 糖化血红蛋白 内皮素 coronary heart disease diabetes mellitus glycated hemoglobin endothelin
  • 相关文献

参考文献9

  • 1Yilmaz MB,Erdem A,Yontar OC,et al.Relationship be tween HbAlc and coronary flow rate in patients with type 2 diabetes mellitus and angiographically normal coronary arteries[J].Turk Kardiyol Dern Ars,2010,38(6):405-410.
  • 2Fumisawa Y,Funase Y,Yamashita K,et al.Systematic a-nalysis of risk factors for coronary heart disease in Japa nese patients with type 2 diabetes:a matched case-control study[J].Atheroscler Thromb,2012,19(10):918-923.
  • 3American Diabetes Association.Diagnosis and classification of diabetes mellitus[J].Diabetes Care,2010,33(1):S62-S69.
  • 4Selvin E,Steffes MW,Zhu H,et al.Glycated hemoglobin,diabetes,and cardiovascular risk in nondiabetic adults[J].N Engl J Med,2010,362(9):800-811.
  • 5Lenters-Westra E,Schindhelm RK,Bilo H J,et al.Haemo-globin Alc:Historical overview and current concepts[J].Diabetes Res Clin Pract,2013,99(2):75-84.
  • 6Leal J,Hayes AJ,Gray AM,et al.Temporal validation of the UKPDS outcomes model using 10-year posttrial moni-toring data[J].Diabetes Care,2013,36(6):1541-1546.
  • 7Ballestshofer BM,Rittig K,Enderle MD,et al.Endotheli al dysfunction is detectable in young normotensive first degree relatives of subjects with type 2 diabetes in associ-ation with insulin resistance [J].Circulation,2000,101(15):1780-1784.
  • 8周小毛,丁爱华.冠心病患者高敏C-反应蛋白与内皮素-1的相关性研究[J].中国现代医生,2008,46(19):12-13. 被引量:6
  • 9Adlbrecht C,Andreas M,Redwan B,et al.Systemic endo thelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature:a ran-domised pilot study[J].Euro Intervention,2012,7(12):1386-1395.

二级参考文献11

  • 1李丽娜,周丽舫,范宝晶.冠心病患者C-反应蛋白与内皮素-1的关系[J].吉林医学,2005,26(12):1333-1333. 被引量:2
  • 2崔瑞华,张素荣,徐自超.冠心病患者血浆同型半胱氨酸和内皮素的临床意义[J].新乡医学院学报,2006,23(1):57-58. 被引量:10
  • 3张庆勇,葛均波,朱建华,陈君柱,张良惠,钱菊英.肿瘤坏死因子及内皮素的异常与心肌微循环功能障碍程度相关性的研究[J].中华心血管病杂志,2006,34(7):635-638. 被引量:7
  • 4李华,毛绍芬.冠心病介入治疗前后C-反应蛋白的变化及临床意义[J].中国医药导报,2007,4(01X):63-64. 被引量:4
  • 5[1]Marai I,Shechter M,Langevitz P,et al.Anti-cardiolipin antibodies and endothelial function in patients with coronary artery dlsease[J].Am J Cardiol,2008,101(8):1094-1097.
  • 6[2]Oren H,Erbay AR,Balci M,et a1.Role of novel biomarkers of inflammation in patients with stable coronary heart disease[J].Angiology,2007,58(2):148-155.
  • 7[3]Taylor AJ,Bobik A,Richards M,et a1.Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease[J].Am Heart J,2004,148(2):10.
  • 8[4]Burke AP,Tracy RP,Kolodgie F,et a1.Elevated C-reactive protein values and atheroselerosis in sudden corenazy death:association with different pathologies[J].Circulation,2002,105(17):2019-2023.
  • 9[8]Anderson R,Dart AM,Starr J,et a1.Plasma C-resetive protein,but not protein S,VCAM-1,von Willebrand factor or P-selectin,is associated with endothelium dysfunction in coronary artery disease[J].Atherosclerosis,2004,172(2):345-351.
  • 10[9]Verma S,Li SH,Badiwala MV,et a1.Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenie effects of C-reactive protein[J].Circulation,2002,105(16):1890-1896.

同被引文献111

引证文献12

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部